HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Phillips Van-Heusen Q2

This article was originally published in The Rose Sheet

Executive Summary

Firm records $552.4 mil. in revenue for the second quarter, a 20% increase versus the comparable period a year ago, driven by a 27% increase in the firm's Calvin Klein licensing business, in particular its fragrance business with strong performance from CKIN2U fragrance and increased sales of men's and women's Euphoria fragrance, both of which are licensed, marketed and distributed by Coty. "The global demand for the Calvin Klein brand continues to expand as we introduce new product categories and enter into new markets around the world," Chairman and CEO Emanuel Chirico said...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014935

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel